Stock Alert: Vaxart Shares Up On Coronavirus Vaccine Hopes

(RTTNews) - Vaxart Inc. (VXRT) shares are rising above 16% in pre-market today, extending the 6% rally in the previous session. The stock has been trading between $0.25 and $5.00 in the past one year, and closed Friday's trade at $2.56, up 16 cents or 6.67%. VXRT is currently up 42 cents or 16.41% to $2.98 in pre-market session.

Vaxart is a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet. The company's oral vaccines are based on its proprietary oral vaccine platform known as VAAST and are designed to activate the immune system of the gut, generating broad systemic and local responses.

In January, the company initiated a program to develop a coronavirus vaccine candidate based on its proprietary oral vaccine platform, VAAST.

The Coronavirus is identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. To date, Vaxart has conducted multiple clinical trials with vaccines based on its VAAST platform, demonstrating its oral tablet vaccines consistently generate robust mucosal responses in humans.